Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SLE Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00268567
What this trial is testing

Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

Who this might be right for
Nephritis, Lupus
Peking University
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Testing effectiveness (Phase 2)Study completedNCT03200002
What this trial is testing

Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis

Who this might be right for
To Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis Patients
Chitwan Medical College 49
Not applicableLooking for participantsNCT07666711
What this trial is testing

Biomarker Development for Autoimmune Disorders Involving the Kidneys

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Oslo University Hospital 500
Not applicableStudy completedNCT03828071
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Nanjing University School of Medicine 22
Not applicableUnknownNCT02403115
What this trial is testing

Prediction of Outcome of Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Istituto Giannina Gaslini 800
Post-approval studies (Phase 4)Ended earlyNCT02226341
What this trial is testing

ACTHar in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Columbia University 8
Not applicableUnknownNCT03958851
What this trial is testing

Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 120
Large-scale testing (Phase 3)Active Not RecruitingNCT04221477
What this trial is testing

Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 271
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Testing effectiveness (Phase 2)Looking for participantsNCT07053800
What this trial is testing

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Autolus Limited 35
Large-scale testing (Phase 3)Study completedNCT00404794
What this trial is testing

Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis

Who this might be right for
Lupus NephritisGlomerulonephritis, Membranous
Hospital Authority, Hong Kong 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Large-scale testing (Phase 3)Looking for participantsNCT06711887
What this trial is testing

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 348
Large-scale testing (Phase 3)Active Not RecruitingNCT05138133
What this trial is testing

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
AstraZeneca 363
Not applicableNot Yet RecruitingNCT07719322
What this trial is testing

Non Invasive Assessment of Subclinical Atherosclerosis and Cardiovascular Risk Using TYG Index in Lupus Nephritis

Who this might be right for
Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)
Assiut University 156
Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24
Large-scale testing (Phase 3)WithdrawnNCT01299922
What this trial is testing

Clinical Trial Treatment in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Hospital Universitario Fundación Alcorcón
Not applicableStudy completedNCT02319525
What this trial is testing

Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus

Who this might be right for
Systemic Lupus Erythematosus
University of Alabama at Birmingham 301
Large-scale testing (Phase 3)Ended earlyNCT00626197
What this trial is testing

Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Genentech, Inc. 381
Next Page